Relaunch

Quote
I’m still waiting for when this product is going to be “taking off” and we will make actual money because maybe 10-20 reps made decent money out of 191 in a LAUNCH. The bonus plan is awful, the “prizes” are awful except the yeti. In the meantime I will keep looking for another and better opportunity.
 






anonymous said:
I’m still waiting for when this product is going to be “taking off” and we will make actual money because maybe 10-20 reps made decent money out of 191 in a LAUNCH. The bonus plan is awful, the “prizes” are awful except the yeti. In the meantime I will keep looking for another and better opportunity.
Click to expand...

trash
 










































anonymous said:
Our lead investigator Mattingly has Qelbree positioned for patients with a history of abuse or for parents that don’t want their child on a stimulant.

Any more questions on why this product is a failure?
Click to expand...

im not happy w the company, but you must not be working or engaging w your HCP’s… “parents who don’t want children on stimulants”… sir or madam that’s basically every parent. No parent ever wakes up and thinks “yes I want my child on a controlled med”.

if your not gonna give the med a shot then you prob shouldn’t just rain negative comments bc your comment makes zero sense to me - that’s a lot of opportunity.

Parents who care don’t want kids on stims that = majority of non-behavioral market.
Kids in system have high potential to abuse that = other 1/2 of market.
Obviously we aren’t going to get the whole pie, prob not even 1/2 the pie. But if the med works as the studies claim we should do fairly well.
 
























anonymous said:
im not happy w the company, but you must not be working or engaging w your HCP’s… “parents who don’t want children on stimulants”… sir or madam that’s basically every parent. No parent ever wakes up and thinks “yes I want my child on a controlled med”.

if your not gonna give the med a shot then you prob shouldn’t just rain negative comments bc your comment makes zero sense to me - that’s a lot of opportunity.

Parents who care don’t want kids on stims that = majority of non-behavioral market.
Kids in system have high potential to abuse that = other 1/2 of market.
Obviously we aren’t going to get the whole pie, prob not even 1/2 the pie. But if the med works as the studies claim we should do fairly well.
Click to expand...

You’re an idiot. Do you even know who Mattingly is? The fact he niched the product on a National teleconference just buries this product even more.
 


















I will enjoy turning in my two week notice ……I am assuming they don’t do exit interviews…if they do that will be a waste of my time since nothing will ever change at Supernus
 






anonymous said:
I will enjoy turning in my two week notice ……I am assuming they don’t do exit interviews…if they do that will be a waste of my time since nothing will ever change at Supernus
Click to expand...

about time.

we will enjoy filling your territory with someone, younger, cheaper, more hungry and hotter.

don’t let the door hit you on the way out.
 












anonymous said:
about time.

we will enjoy filling your territory with someone, younger, cheaper, more hungry and hotter.

don’t let the door hit you on the way out.
Click to expand...

you are correct. Until that younger, cheaper person realize how bad they are getting paid and the cycle goes on. Don't fool your self, this place is the at the bottom of Pharma companies. You work at a company that sells a generic product at a 1000% markup. You are what's wrong with the health system. Have fun selling generic drugs for the rest of your life. Also, make sure to memorize your Ssp
 












Top Bottom
Back
Quote